Corcept Therapeutics Inc Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.47%97.77%97.92%98.20%98.42%98.56%98.66%98.66%98.39%
EBT Margin -69,537.93%-2,560.75%129,416.00%10.01%33.17%36.68%38.07%37.19%34.16%28.91%25.82%23.92%
EBIT Margin -69,827.59%-2,705.82%129,328.00%12.52%33.20%35.62%36.41%36.23%34.01%28.03%22.24%20.29%
EBITDA Margin -69,827.59%-2,705.82%129,328.00%10.01%81.06%30.02%30.84%30.00%30.57%28.03%22.24%20.29%
Operating Margin -69,827.59%-2,705.82%129,328.00%12.52%33.20%35.62%36.41%36.23%34.01%28.03%22.24%20.29%
Net Margin -69,537.93%-2,560.75%129,416.00%10.01%81.11%30.01%30.73%29.96%30.74%25.20%21.87%20.70%
FCF Margin -61,958.62%-2,197.73%109,700.00%22.38%38.01%45.92%44.06%42.59%45.75%29.84%26.31%29.02%
Efficiency
Inventory Average 3.45M4.65M5.08M5.17M4.95M5.54M6.92M10.07M
Assets Average 22.14M24.81M144.65M266.12M362.00M492.02M497.74M503.59M602.47M731.03M
Equity Average 19.50M21.67M116.17M233.43M323.53M447.26M449.57M438.82M504.27M593.15M
Invested Capital 22.09M21.24M86.38M190.97M275.88M371.18M523.34M375.81M501.84M506.70M679.59M
Asset Utilization Ratio 0.000.041.100.940.850.720.740.800.800.92
Leverage & Solvency
Interest Coverage Ratio -0.00M-0.00M-0.00M
Debt to Equity 0.35
Debt Ratio 0.21
Equity Ratio 0.900.850.600.870.890.900.920.890.860.820.81
Times Interest Earned -0.00M-0.00M-0.00M
Valuation
Enterprise Value 31.49M254.82M288.07M754.55M1,972.34M1,335.94M1,106.83M2,598.39M2,062.41M1,754.70M2,979.86M4,896.29M
Market Capitalization 173.68M279.40M288.07M806.09M2,061.08M1,542.70M1,382.80M3,039.08M2,285.95M2,186.37M3,348.08M5,279.62M
Return Ratios
Return on Sales -695.38%-25.61%0.10%0.81%0.30%0.31%0.30%0.31%0.25%0.22%0.21%
Return on Capital Employed -1.03%-1.31%0.46%0.39%0.35%0.29%0.28%0.26%0.22%0.23%
Return on Invested Capital 0.31%0.28%0.23%0.25%0.22%0.18%0.20%
Return on Assets -0.91%-1.05%0.89%0.28%0.26%0.22%0.23%0.20%0.18%0.19%
Return on Equity -1.03%-1.20%1.11%0.32%0.29%0.24%0.25%0.23%0.21%0.24%